Abstract
Purpose
The purpose of this study was to demonstrate if childhood acute lymphoblastic leukemia (ALL) survivors exposed to chemotherapy (i.e., doxorubicin) are able to achieve a safe maximal cardiopulmonary exercise test (CPET).
Methods
A total of 250 childhood ALL survivors were eligible to undergo a CPET on ergocycle. Analyses were performed in 216 survivors and stratified in regard to their prognostic risk groups: 99 survivors (55 males and 44 females) at standard risk and 117 survivors (56 males and 61 females) at high risk.
Results
Results showed that 100% (n = 216) of survivors completed a maximal CPET confirmed by the achievement of two out of three of the following criteria: 197 survivors (91.2%) reached a peak RER value of ≥ 1.15, 197 survivors (91.2%) reached a RPE score > 7, and 210 survivors (97.2%) reached a maximal heart rate ≥ 85% of the predicted value. Linear regression analysis showed a significant association between the survivors’ cumulative dose of doxorubicin and their VO2 peak measured. Two non-fatal adverse events were observed and reported at the end of the maximal CPET, while non-fatal adverse events were reported in 5 survivors during the recovery period. None of these events resulted in a long-term complication.
Conclusion
Childhood ALL survivors with prior exposure to chemotherapy can achieve a safe maximal CPET. They were able of achieving a maximal exercise test without being limited by symptoms, potential overprotection, or musculoskeletal issues. Thus, it should be the norm to realize a CPET prior a physical activity program to propose an optimal prescription. This study provides important information regarding the maximal physiological parameters that childhood ALL survivors are able to reach and have important clinical implications in the exercise and oncology field for this population of survivors.
Similar content being viewed by others
References
Sarfati D, Koczwara B, Jackson C (2016) The impact of comorbidity on cancer and its treatment. CA Cancer J Clin 66(4):337–350
Caru M, Samoilenko M, Drouin S, Lemay V, Kern L, Romo L, Bertout L, Lefebvre G, Andelfinger G, Krajinovic M, Laverdiere C, Sinnett D, Curnier D (2019) Childhood acute lymphoblastic leukemia survivors have a substantially lower cardiorespiratory fitness level than healthy Canadians despite a clinically equivalent level of physical activity. J Adolesc Young Adult Oncol 8(6):674–683
Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J, European Association for Cardiovascular Prevention & Rehabilitation., American Heart Association (2012) EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 126(18):2261–2274
Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky M, Joy AA et al (2007) Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung Cancer 55(2):225–232
Kim S, Song IC, Jee S (2017) Cardiopulmonary exercise test in leukemia patients after chemotherapy: a feasibility study. Ann Rehabil Med 41(3):456–464
Thornton J (1997) Overcoming ‘protected child syndrome’ kids, exercise, and chronic illness. Phys Sportsmed 25(11):97–100
Mody R, Li S, Dover DC, Sallan S, Leisenring W, Oeffinger KC, Yasui Y, Robison LL, Neglia JP (2008) Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 111(12):5515–5523
De Caro E, Fioredda F, Calevo MG, Smeraldi A, Saitta M, Hanau G et al (2006) Exercise capacity in apparently healthy survivors of cancer. Arch Dis Child 91(1):47–51
Ness KK, Plana JC, Joshi VM, Luepker RV, Durand JB, Green DM, Partin RE, Santucci AK, Howell RM, Srivastava DK, Hudson MM, Robison LL, Armstrong GT (2019) Exercise intolerance, mortality, and organ system impairment in adult survivors of childhood cancer. J Clin Oncol 38(1):29–42
American Thoracic S (2003) American College of Chest P. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167(2):211–277
Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS et al (2019) Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 51(11):2375–2390
Silverman LB, Stevenson KE, O'Brien JE, Asselin BL, Barr RD, Clavell L, Cole PD, Kelly KM, Laverdiere C, Michon B, Schorin MA, Schwartz CL, O'Holleran EW, Neuberg DS, Cohen HJ, Sallan SE (2010) Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia. 24(2):320–334
Marcoux S, Drouin S, Laverdiere C, Alos N, Andelfinger GU, Bertout L et al (2017) The PETALE study: late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors. Pediatr Blood Cancer 64(6):1–8
Bar-Or O, Rowland TW. Pediatric exercise medicine: from physiologic principles to health care application. Champaign: Human Kinetics 2004
Paridon SM, Alpert BS, Boas SR, Cabrera ME, Caldarera LL, Daniels SR, Kimball TR, Knilans TK, Nixon PA, Rhodes J, Yetman AT, American Heart Association Council on Cardiovascular Disease in the Young, Committee on Atherosclerosis, Hypertension, and Obesity in Youth (2006) Clinical stress testing in the pediatric age group: a statement from the American Heart Association Council on Cardiovascular Disease in the Young, Committee on Atherosclerosis, Hypertension, and Obesity in Youth. Circulation. 113(15):1905–1920
Buchfuhrer MJ, Hansen JE, Robinson TE, Sue DY, Wasserman K, Whipp BJ (1983) Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol Respir Environ Exerc Physiol 55(5):1558–1564
Taylor HL, Jacobs DR Jr, Schucker B, Knudsen J, Leon AS, Debacker G (1978) A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 31(12):741–755
Kriska AM, Caspersen CJ (1997) Introduction to a collection of physical activity questionnaires. Med Sci Sports Exerc 29(6):5–9
Montoye HJ (1971) Estimation of habitual physical activity by questionnaire and interview. Am J Clin Nutr 24(9):1113–1118
Ridley K, Ainsworth BE, Olds TS (2008) Development of a compendium of energy expenditures for youth. Int J Behav Nutr Phys Act 5(45):1–8
Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277–314
Ueda T, Kawakami R, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe M, Kawata H, Uemura S, Saito Y (2015) Left ventricular ejection fraction (EF) of 55% as cutoff for late transition from heart failure (HF) with preserved EF to HF with mildly reduced EF. Circulation J 79(10):2209–2215
Powell AW, Nagarajan R, Mays WA, Chin C, Knilans TK, Knecht SK et al (2018) Cardiopulmonary aerobic fitness assessment during maximal and submaximal exercise testing in pediatric oncology patients after chemotherapy. Am J Clin Oncol 41(11):1058–1061
Phillips NS, Howell CR, Lanctot JQ, Partin RE, Pui C-H, Hudson MM et al (2019) Physical fitness and neurocognitive outcomes in adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime cohort. Cancer Online ahead of print
Caru M, Corbin D, Perie D, Lemay V, Delfrate J, Drouin S et al (2019) Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors. Clin Res Cardiol 108(9):1000–1008
Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324(12):808–815
Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, Colan SD (2005) Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23(12):2629–2636
Mizrahi D, Fardell JE, Cohn RJ, Partin RE, Howell CR, Hudson MM et al (2019) The 6-minute walk test is a good predictor of cardiorespiratory fitness in childhood cancer survivors when access to comprehensive testing is limited. Int J Cancer Online ahead of print
Labonté J, Caru M, Lemay V, Alos N, Drouin S, Bertout L, Andelfinger G, Krajinovic M, Laverdière C, Sinnett D, Curnier D (2020) Developing and validating equations to predict [Formula: see text]O(2) peak from the 6MWT in childhood ALL survivors. Disabil Rehabil:1–8
Lemay V, Caru M, Samoilenko M, Drouin S, Alos N, Lefebvre G, Levy E, Lippé S, Marcil V, Sultan S, Bertout L, Krajinovic M, Laverdière C, Raboisson MJ, Sinnett D, Andelfinger G, Curnier D (2019) Prevention of long-term adverse health outcomes with cardiorespiratory fitness and physical activity in childhood acute lymphoblastic leukemia survivors. J Pediatr Hematol Oncol 41(7):e450–e4e8
Santa Mina D, Au D, Papadopoulos E, O'Neill M, Diniz C, Dolan L et al. Aerobic capacity attainment and reasons for cardiopulmonary exercise test termination in people with cancer: a descriptive, retrospective analysis from a single laboratory. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2020;[Online ahead of print]
Takken T, Blank AC, Hulzebos EH, van Brussel M, Groen WG, Helders PJ (2009) Cardiopulmonary exercise testing in congenital heart disease: equipment and test protocols. Netherlands Heart J 17(9):339–344
Wolfe KR, Hunter GR, Madan-Swain A, Reddy AT, Baños J, Kana RK (2012) Cardiorespiratory fitness in survivors of pediatric posterior fossa tumor. J Pediatr Hematol Oncol 34(6):e222–e2e7
Braam KI, van Dijk-Lokkart EM, Kaspers GJL, Takken T, Huisman J, Bierings MB, Merks JHM, van de Heuvel-Eibrink MM, van Dulmen–den Broeder E, Veening MA (2016) Cardiorespiratory fitness and physical activity in children with cancer. Support Care Cancer 24(5):2259–2268
Skalski J, Allison TG, Miller TD (2012) The safety of cardiopulmonary exercise testing in a population with high-risk cardiovascular diseases. Circulation. 126(21):2465–2472
Lemay V, Caru M, Samoilenko M, Drouin S, Mathieu M-E, Bertout L et al (2019) Physical activity and sedentary behaviors in childhood acute lymphoblastic leukemia survivors. J Pediatr Hematol Oncol 42(1):53–60
Degens H, Stasiulis A, Skurvydas A, Statkeviciene B, Venckunas T (2019) Physiological comparison between non-athletes, endurance, power and team athletes. Eur J Appl Physiol 119(6):1377–1386
Schmitz KH, Campbell AM, Stuiver MM, Pinto BM, Schwartz AL, Morris GS, Ligibel JA, Cheville A, Galvão DA, Alfano CM, Patel AV, Hue T, Gerber LH, Sallis R, Gusani NJ, Stout NL, Chan L, Flowers F, Doyle C, Helmrich S, Bain W, Sokolof J, Winters-Stone KM, Campbell KL, Matthews CE (2019) Exercise is medicine in oncology: engaging clinicians to help patients move through cancer. CA Cancer J Clin 69(6):468–484
Caru M, Petrykey K, Drouin S, Beaulieu P, St-Onge P, Lemay V, Bertout L, Laverdiere C, Andelfinger G, Krajinovic M, Sinnett D, Curnier D (2019) Identification of genetic association between cardiorespiratory fitness and the trainability genes in childhood acute lymphoblastic leukemia survivors. BMC Cancer 19(1):443–450
Klika R, Tamburini A, Galanti G, Mascherini G, Stefani L (2018) The role of exercise in pediatric and adolescent cancers: a review of assessments and suggestions for clinical implementation. J Funct Morphol Kinesiol 3(1):1–19
Scharhag-Rosenberger F, Wiskemann J, Scharhag J (2015) Cardiopulmonary exercise testing in cancer patients: should we really refrain from considering it for preparticipation screening? Oncologist. 20(2):228
Riebe D, Ehrman JK, Liguori G, Magal M (2018) ACSM’s guidelines for exercise testing and prescription. 10th ed. American College of Sports Medicine, editor. Wolters Kluwer, Philadelphia
Acknowledgments
We appreciate the assistance of Ariane Levesque (McGill University) for her review of the article in the English language.
Funding
This work was supported by the Institute of Cancer Research (ICR) of the Canadian Institutes of Health Research (CIHR), in collaboration with C17 Council, Canadian Cancer Society (CCS), Cancer Research Society (CRS), Garron Family Cancer Centre at the Hospital for Sick Children, Ontario Institute for Cancer Research (OICR), and Pediatric Oncology Group of Ontario (POGO). This research was also supported in part by PhD study grants from the Canadian Research Data Centre Network and the Quebec inter-University Centre for Social Statistics, Cole Foundation, Fonds de Recherche du Québec – Santé (FRQS), Sainte-Justine University Hospital Center Foundation and Foundation of Stars. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Written informed consent was obtained from every patient or parent/legal guardian. The PETALE study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Review Committee of SJUHC (2013-3607).
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Caru, M., Laverdière, C., Lemay, V. et al. Maximal cardiopulmonary exercise testing in childhood acute lymphoblastic leukemia survivors exposed to chemotherapy. Support Care Cancer 29, 987–996 (2021). https://doi.org/10.1007/s00520-020-05582-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-020-05582-y